Medical News: FDA: Data Mixed on HIV Drug's MI Risk - in Product Alert, Prescriptions from MedPage Today
Links shared publicly online about this topic.
- 469total visits
Medical News: FDA: Data Mixed on HIV Drug's MI Risk - in Product Alert, Prescriptions from MedPage Today
WASHINGTON -- The FDA said it could not confirm initial reports that the HIV drug abacavir (Ziagen, Trizivir, Epzicom) raises the risk of myocardial infarction.
View full resource at medpagetoday.com
Tags: Heart, Heart Disease, Heart Attack, HIV Medication, Thrombotic Event, FDA, Ziagen, Medical
Most Recently Shared on March 2, 2011 at 2:34 pm By:
RT @the_pillbook: #Heart attack data on Abacavir cannot be confirmed: FDA http://ow.ly/46lwm
Medical News: FDA: Data Mixed on HIV Drug's MI Risk - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA said it could not confirm initial reports that the HIV drug abacavir (Ziagen, Trizivir, Epzicom) raises the risk of myocardial infarction.” View full resource at medpagetoday.com
Most Recently Shared on March 1, 2011 at 9:37 pm By:
FDA: Data Mixed on Abacavir MI Risk http://bit.ly/dF5lgT
Advertisement
